Search Results - "Desai, Rishi J."

Refine Results
  1. 1

    Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners by Desai, Rishi J, Franklin, Jessica M

    Published in BMJ (Online) (23-10-2019)
    “…This report aims to provide methodological guidance to help practitioners select the most appropriate weighting method based on propensity scores for their…”
    Get full text
    Journal Article
  2. 2

    Network-based approach to prediction and population-based validation of in silico drug repurposing by Cheng, Feixiong, Desai, Rishi J., Handy, Diane E., Wang, Ruisheng, Schneeweiss, Sebastian, Barabási, Albert-László, Loscalzo, Joseph

    Published in Nature communications (12-07-2018)
    “…Here we identify hundreds of new drug-disease associations for over 900 FDA-approved drugs by quantifying the network proximity of disease genes and drug…”
    Get full text
    Journal Article
  3. 3

    Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study by Desai, Rishi J., Pawar, Ajinkya, Weinblatt, Michael E., Kim, Seoyoung C.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2019)
    “…Objective To evaluate the risk of venous thromboembolism (VTE) in rheumatoid arthritis (RA) patients receiving tofacitinib versus those receiving tumor…”
    Get full text
    Journal Article
  4. 4

    Lithium Use in Pregnancy and the Risk of Cardiac Malformations by Patorno, Elisabetta, Huybrechts, Krista F, Bateman, Brian T, Cohen, Jacqueline M, Desai, Rishi J, Mogun, Helen, Cohen, Lee S, Hernandez-Diaz, Sonia

    Published in The New England journal of medicine (08-06-2017)
    “…Whereas some prior data had suggested a large increase in the risk of cardiac malformations among offspring of women using lithium in early pregnancy, this…”
    Get full text
    Journal Article
  5. 5

    Increase in Prescription Opioid Use During Pregnancy Among Medicaid-Enrolled Women by Desai, Rishi J., Hernandez-Diaz, Sonia, Bateman, Brian T., Huybrechts, Krista F.

    Published in Obstetrics and gynecology (New York. 1953) (01-05-2014)
    “…To report the prevalence of prescription opioid use and evaluate the trends in a large cohort of Medicaid-enrolled pregnant women. A cohort of pregnancies was…”
    Get full text
    Journal Article
  6. 6

    Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn by Huybrechts, Krista F, Bateman, Brian T, Palmsten, Kristin, Desai, Rishi J, Patorno, Elisabetta, Gopalakrishnan, Chandrasekar, Levin, Raisa, Mogun, Helen, Hernandez-Diaz, Sonia

    “…IMPORTANCE: The association between selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and risk of persistent pulmonary…”
    Get full text
    Journal Article
  7. 7

    Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations by Huybrechts, Krista F, Hernández-Díaz, Sonia, Patorno, Elisabetta, Desai, Rishi J, Mogun, Helen, Dejene, Sara Z, Cohen, Jacqueline M, Panchaud, Alice, Cohen, Lee, Bateman, Brian T

    Published in JAMA psychiatry (Chicago, Ill.) (01-09-2016)
    “…The frequency of antipsychotic (AP) use during pregnancy has approximately doubled during the last decade. However, little is known about their safety for the…”
    Get more information
    Journal Article
  8. 8
  9. 9

    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure by Mahesri, Mufaddal, Chin, Kristyn, Kumar, Abheenava, Barve, Aditya, Studer, Rachel, Lahoz, Raquel, Desai, Rishi J

    Published in PloS one (04-06-2021)
    “…Background Ejection fraction (EF) is an important prognostic factor in heart failure (HF), but administrative claims databases lack information on EF. We…”
    Get full text
    Journal Article
  10. 10

    Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes by Park, Yoonyoung, Hernandez-Diaz, Sonia, Bateman, Brian T, Cohen, Jacqueline M, Desai, Rishi J, Patorno, Elisabetta, Glynn, Robert J, Cohen, Lee S, Mogun, Helen, Huybrechts, Krista F

    Published in The American journal of psychiatry (01-06-2018)
    “…Objective:Some atypical antipsychotics are associated with metabolic side effects, which are risk factors for gestational diabetes. The authors examined the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis by Jin, Yinzhu, Desai, Rishi J, Liu, Jun, Choi, Nam-Kyong, Kim, Seoyoung C

    Published in Arthritis research & therapy (05-07-2017)
    “…Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used for rheumatoid arthritis (RA) treatment. However, little is known based on…”
    Get full text
    Journal Article
  13. 13

    Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset by Patorno, Elisabetta, Hernandez-Diaz, Sonia, Huybrechts, Krista F., Desai, Rishi J., Cohen, Jacqueline M., Mogun, Helen, Bateman, Brian T.

    Published in PLoS medicine (01-09-2020)
    “…BACKGROUNDDespite the widespread use, only sparse information is available on the safety of gabapentin during pregnancy. We sought to evaluate the association…”
    Get full text
    Journal Article
  14. 14

    Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims by Desai, Rishi J, Sarpatwari, Ameet, Dejene, Sara, Khan, Nazleen F, Lii, Joyce, Rogers, James R, Dutcher, Sarah K, Raofi, Saeid, Bohn, Justin, Connolly, John G, Fischer, Michael A, Kesselheim, Aaron S, Gagne, Joshua J

    Published in PLoS medicine (13-03-2019)
    “…To the extent that outcomes are mediated through negative perceptions of generics (the nocebo effect), observational studies comparing brand-name and generic…”
    Get full text
    Journal Article
  15. 15

    An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout by Desai, Rishi J, Franklin, Jessica M, Spoendlin-Allen, Julia, Solomon, Daniel H, Danaei, Goodarz, Kim, Seoyoung C

    Published in PloS one (28-02-2018)
    “…Gout patients have a high burden of co-morbid conditions including diabetes mellitus (DM), chronic kidney disease (CKD), and cardiovascular disease (CVD). We…”
    Get full text
    Journal Article
  16. 16

    Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study by Kang, Eun Ha, Jin, Yinzhu, Brill, Gregory, Lewey, Jennifer, Patorno, Elisabetta, Desai, Rishi J., Kim, Seoyoung C.

    Published in Journal of the American Heart Association (06-02-2018)
    “…Background We examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and…”
    Get full text
    Journal Article
  17. 17

    Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study by Kang, Eun Ha, Jin, Yinzhu, Tong, Angela Y., Desai, Rishi J., Kim, Seoyoung C.

    Published in Arthritis care & research (2010) (01-10-2020)
    “…Objective To compare the risk of serious infections between the use of tumor necrosis factor inhibitors (TNFi) plus methotrexate (MTX) versus triple therapy…”
    Get full text
    Journal Article
  18. 18

    Prospective validation of a dynamic prognostic model for identifying COVID‐19 patients at high risk of rapid deterioration by Lin, Kueiyu Joshua, D'Andrea, Elvira, Desai, Rishi J., Gagne, Joshua J., Liu, Jun, Wang, Shirley V.

    Published in Pharmacoepidemiology and drug safety (01-05-2023)
    “…Background We sought to develop and prospectively validate a dynamic model that incorporates changes in biomarkers to predict rapid clinical deterioration in…”
    Get full text
    Journal Article
  19. 19
  20. 20